Sa2064: NOVEL AI-DRIVEN DETECTION, LOCALISATION AND QUANTIFICATION OF NEUTROPHILS FOR PREDICTION OF EARLY RESPONSE TO THERAPY IN A PHASE 2 ULCERATIVE COLITIS CLINICAL TRIAL
Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Enrico Grisan(University of Padua), Klaus Gottlieb, Brian Hayes(Cork University Hospital), Charles Owen, Valery Naranjo(Universitat Politècnica de València), Irene Zammarchi(APC Microbiome Institute), Rocío del Amor(Universitat Politècnica de València), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Pablo Meseguer(Artificial Intelligence Research Institute), Davide Zardo(Ospedale San Bortolo), Bisi Bode Kolawole(London South Bank University), Subrata Ghosh(University College Cork), Louise Burke(Cork University Hospital), Ujwala Chaudhari(London South Bank University), Valentina Vadori(London South Bank University), William Eastman(Eli Lilly (United States)), Rory Crotty(Cork University Hospital)
Cited by 0
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
|New England Journal of Medicine|2012|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
|Journal of Crohn s and Colitis|2021|540